Natamycin Ophthalmic Suspension
» Natamycin Ophthalmic Suspension is a sterile suspension of Natamycin in a suitable aqueous vehicle. It contains not less than 90.0 percent and not more than 125.0 percent of the labeled amount of C33H47NO13. It contains one or more suitable preservatives.
Packaging and storage—
Preserve in tight, light-resistant containers. The containers or individual cartons are sealed and tamper-proof so that sterility is assured at time of first use.
Identification—
Transfer a volume of Ophthalmic Suspension, equivalent to about 50 mg of natamycin, to a 200-mL volumetric flask, and add water to make a volume of 5 mL. Proceed as directed in the Identification test under Natamycin, beginning with “Add 100 mL of a 1 in 1000 solution of glacial acetic acid in methanol:” the specified result is obtained.
Sterility 
71
—
It meets the requirements as directed for Direct Inoculation of the Culture Medium under Test for Sterility of the Product to be Examined, using 0.25 mL of the Ophthalmic Suspension taken from each container.
71—
It meets the requirements as directed for Direct Inoculation of the Culture Medium under Test for Sterility of the Product to be Examined, using 0.25 mL of the Ophthalmic Suspension taken from each container.
pH 791:
between 5.0 and 7.5.
791:
between 5.0 and 7.5.
Assay—
[note—Throughout the Assay protect from direct light all solutions containing natamycin.]
Mobile phase
, Standard preparation, Resolution solution, and Chromatographic system—Proceed as directed in the Assay under Natamycin.
Assay preparation—
Transfer an accurately measured volume of Ophthalmic Suspension, equivalent to about 50 mg of natamycin, to a 250-mL volumetric flask. Add 12.5 mL of tetrahydrofuran, and sonicate for 10 minutes. Add 150 mL of methanol, and swirl to dissolve. Add 60 mL of water, and mix. Allow to cool to room temperature. Dilute with water to volume, and mix. Filter this solution through a suitable membrane filter of 0.5-µm or finer porosity.
Procedure—
Proceed as directed in the Assay under Natamycin. Calculate the quantity, in mg, of C33H47NO13 in each mL of the Ophthalmic Suspension taken by the formula:
0.25C(PS / V)(rU / rS)
in which C is the concentration, in mg per mL, of USP Natamycin RS in the Standard preparation, PS is the stated content, in µg per mg, of USP Natamycin RS, V is the volume, in mL, of Ophthalmic Suspension taken, and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
Chromatographic Column—
| Topic/Question | Contact | Expert Committee |
| Monograph | Ahalya Wise, M.S.
Scientist 1-301-816-8161 |
(MDANT05) Monograph Development-Antibiotics |
| Reference Standards | Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org |
|
| 71 |
Radhakrishna S Tirumalai, Ph.D.
Senior Scientist 1-301-816-8339 |
(MSA05) Microbiology and Sterility Assurance |
USP32–NF27 Page 3043
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.